TFO
XLRN

Tarbox Family Office’s Acceleron Pharma XLRN Stock Holding History

Tarbox Family Office’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10
Closed -$2K – 1213
2021
Q3 		$2K Hold
10
– – ﹤0.01% 1002
2021
Q2 		$1K Hold
10
– – ﹤0.01% 1132
2021
Q1 		$1K Hold
10
– – ﹤0.01% 1132
2020
Q4 		$1K Hold
10
– – ﹤0.01% 1117
2020
Q3 		$1K Hold
10
– – ﹤0.01% 1124
2020
Q2 		$1K Hold
10
– – ﹤0.01% 1133
2020
Q1 		$1K Buy
+10
New +$777 ﹤0.01% 1076

Tarbox Family Office's XLRN Position: Q4 2021 in Review

Tarbox Family Office sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 10 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in XLRN in Q1 2020 and held it in 7 quarters. The position peaked at $2K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Tarbox Family Office reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Tarbox Family Office sold 10 Acceleron Pharma shares in Q4 2021, an estimated $2K.
  • Tarbox Family Office first reported a position in Acceleron Pharma in Q1 2020 and held it in 7 quarters.
  • Tarbox Family Office's Acceleron Pharma position peaked at $2K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Tarbox Family Office's 13F filing for Q4 2021, filed 6 Jan 2022.